BSE filing, BSE: 544738. Summary written from the filing by ALFA Finder's alert engine.
Speciality Medicines Ltd: key numbers
- Share price
- ₹140.00
- Market cap
- ₹123.0 Cr
- Revenue (annual)
- ₹75.29 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 9.4×Sector 45.9×
- Promoter holding
- 43.43%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Speciality Medicines Ltd
All →Speciality Medicines Other Announcement
Speciality Medicines Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Speciality Medicines Annual General Meeting
Speciality Medicines Limited conducted its 5th Annual General Meeting on September 28, 2026. Shareholders considered the adoption of FY26 audited financial statements and the re-appointment of Director Sumit Goyani.
Speciality Medicines Annual Report
Speciality Medicines Limited has submitted its Annual Report for the financial year 2025-26 to the exchange, complying with regulatory filing requirements.
Speciality Medicines Annual General Meeting
Speciality Medicines Limited scheduled its 5th Annual General Meeting for September 28, 2026. The board also approved the draft Directors' Report for FY 2025-26.
Speciality Medicines Regulatory Approval
Speciality Medicines Limited received regulatory approval in Ethiopia for two additional pharmaceutical formulations, Olanzapine and Diazepam tablets. The company now has 12 registered products in Ethiopia.
Speciality Medicines Business Update
Speciality Medicines Limited received regulatory approval for two new products, Olanzapine and Diazepam tablets, in the Ethiopian market, strengthening its international export portfolio.
Other price movement clarification announcements
All →Dhvija Finance Price Movement Clarification
Dhvija Finance Ltd stated the price movement is market-driven with no undisclosed events, confirming full regulatory compliance. No impending announcements exist beyond upcoming Q3 results.
Solex Energy Price Movement Clarification
Solex Energy clarified to the exchange that no specific US market negotiations exist. The company confirmed no unpublished material information requiring disclosure.
Gulf Oil Lubricants India Price Movement Clarification
Gulf Oil Lubricants clarified a news item about Gulf Oil International's global expansion plans, stating no negotiations were entered into. The price movement is described as market-driven with no undisclosed event.
Anna Infrastructures Price Movement Clarification
Anna Infrastructures responded to a BSE query on significant price movement, stating no undisclosed price-sensitive information is withheld. It attributes the share price movement to market conditions.
Tera Software Price Movement Clarification
Tera Software responded to BSE and NSE surveillance queries on recent share price movement. The company states there is no unannounced material information and the move is market-driven.
Olatech Solutions Price Movement Clarification
Olatech Solutions said its share price movement was purely market driven, responding to a BSE query. It stated it remains compliant with Regulation 30 disclosures.